Evidence map›Paper›PMID 36952637›Full record

ArticleAngewandte Chemie (International ed. in English)2023

Hydrogen-Atom-Transfer-Initiated Radical/Polar Crossover Annulation Cascade for Expedient Access to Complex Tetralins.

Lucas K Johnson, Griffin L Barnes, Sebastian A Fernandez, Christopher D Vanderwal

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Directed Hydrogen Atom Transfer for Selective Reactions of Polyenols.Journal of the American Chemical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lucas K Johnson1102 Natural Sciences II, Department of Chemistry, University of California, 92697-2025, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-4215-5548
Griffin L Barnes1102 Natural Sciences II, Department of Chemistry, University of California, 92697-2025, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-5731-4380
Sebastian A Fernandez1102 Natural Sciences II, Department of Chemistry, University of California, 92697-2025, Irvine, CA, USA.ORCID http://orcid.org/0009-0002-5076-3551
Christopher D Vanderwal1102 Natural Sciences II, Department of Chemistry, University of California, 92697-2025, Irvine, CA, USA.ORCID http://orcid.org/0000-0001-7218-4521

Funding

Chemical Synthesis of Bioactive DiterpenoidsR35GM145252 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christopher D Vanderwal · 2022 to 2026
$2.1M
Cyclization Cascades to Access Bioactive DiterpenoidsR01GM129264 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI VANDERWAL, CHRISTOPHER D · 2018 to 2021
$1.6M
NIGMS NIH HHS GM-129264NIGMS NIH HHS GM-145252NIGMS NIH HHS R01 GM129264NIGMS NIH HHS R35 GM145252
6 · The paper itself

Abstract

A radical/polar crossover annulation between allyl-substituted arenes and electron-deficient alkenes is described. Cobalt-catalyzed hydrogen atom transfer (HAT) facilitates tandem radical C-C bond formation that generates functionalized tetralin products in the face of potentially problematic hydrofluorination, hydroalkoxylation, hydrogenation, alkene isomerization, and radical polymerization reactions. The reactions proceed under mild conditions that tolerate many functional groups, leading to a broad substrate scope. This powerful ring-forming reaction very quickly assembles complex tetralins that are the formal products of the largely infeasible Diels-Alder cycloadditions of styrenes.

Indexed as

AnnulationGiese AdditionHydrogen Atom TransferRadicalRadical/Polar Crossover

Identifiers

PMID36952637
PMCPMC10164078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.